当前位置：首页 > 文献互助 > 互助详情

Recurrent Ischemic Stroke: Prevention Strategies复制

用户wxb8loTerxGI 1小时前 11 10 求助中 帖子自动结束时间: 2026-01-24 09:57:12

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

B Ford, MM Dore, TR Koehn
American Family Physician, 2026
aafp.org
Recurrent ischemic stroke is a significant health concern, with 12% of patients experiencing recurrence within 5 years of the initial stroke. Effective prevention strategies focus on identifying stroke subtypes, controlling cardiovascular risk factors, and tailoring treatment based on stroke type to reduce risk of recurrence.

上一篇：Determination of clarithromycin in human plasma by liquid chromatography-tandem mass spectrometry: Validation and application in clinical pharmacokinetic study

下一篇：Photochromic Materials: Preparation, Properties and Applications

互助时间线

2026-01-19 09:57:12 [发起求助]

最新发布的求助

The Potential Role of Anti-Inflammatory Therapy in Heart Failure Treatment 26分钟前
ACE2 in the renin–angiotensin system 26分钟前
Atherosclerotic coronary plaque regression from lipid-lowering therapies: a meta-analysis and meta-regression 31分钟前
An Unsupervised Learning Approach for Reconstructing 3T-Like Images From 0.3T MRI Without Paired Training Data 33分钟前
One-Pot Synthesis of Sulfonamides from Unactivated Acids and Amines via Aromatic Decarboxylative Halosulfonylation 36分钟前
Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study 39分钟前
Comparative Efficacy of China's Domestic versus Imported PD-1/PD-L1 Inhibitor-Based Combinations as First-Line Therapy for Advanced Non-small Cell Lung … 46分钟前
Therapies leading to coronary atherosclerosis plaque regression: Part 1: Atherosclerosis Pathophysiology and Imaging Evaluation 55分钟前
Characterisation of the Capsid Particle Population in rAAV Products - british pharmacopoeia[1766623623.3585732.html] 57分钟前
EMI Cancellation for Shielding-Free Ultra-Low-Field MRI 1小时前
乙胺嘧啶片 1小时前
Comparative Efficacy of China's Domestic versus Imported PD-1/PD-L1 Inhibitor-Based Combinations as First-Line Therapy for Advanced Non-small Cell Lung … 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com